PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 64 filers reported holding PROQR THRAPEUTICS N V in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $127,000 | -96.7% | 15,896 | -96.5% | 0.03% | -93.7% |
| Q3 2021 | $3,793,000 | +24.2% | 453,182 | 0.0% | 0.41% | +50.0% |
| Q2 2021 | $3,054,000 | +1.9% | 453,182 | 0.0% | 0.27% | +19.1% |
| Q1 2021 | $2,996,000 | +57.4% | 453,182 | 0.0% | 0.23% | +56.5% |
| Q4 2020 | $1,903,000 | -30.9% | 453,182 | 0.0% | 0.15% | -52.6% |
| Q2 2020 | $2,755,000 | +12.1% | 453,182 | +1.2% | 0.31% | -34.0% |
| Q1 2020 | $2,458,000 | -44.7% | 447,657 | -0.3% | 0.47% | -70.1% |
| Q4 2019 | $4,448,000 | +65.8% | 448,880 | -3.6% | 1.57% | -6.5% |
| Q3 2019 | $2,682,000 | -36.7% | 465,580 | 0.0% | 1.68% | +10.9% |
| Q2 2019 | $4,237,000 | +379.8% | 465,580 | +631.1% | 1.52% | +791.8% |
| Q1 2019 | $883,000 | – | 63,680 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |